A new study out of Penn State shows good results using Naltrexone to reduce inflammation in Crohn’s.
Eighty-eight percent of those treated with naltrexone had at least a 70-point decline in Crohn’s Disease Activity Index scores compared to 40 percent of placebo-treated patients.
The sample group wasn’t huge, but the study was double-blind and the difference between placebo and naltrexone results seems to be cause for optimism for those seeking alternative medications to treat their Crohn’s.
UPDATE: Penn State did a study of low dose Naltrexone (LDN) in 2007 with good results.
Eating SCD 
0 Responses to “Study results: Naltrexone reduces Crohn’s inflammation”